Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Prepaid Assets (2022 - 2026)

Genelux (GNLX) posted Prepaid Assets of $545000.0 for Q1 2026, up 1.87% on a QoQ basis from $535000.0 in Q4 2025.

Analysis

Genelux (GNLX) Prepaid Assets (2022 - 2026) Analysis & Trends

Genelux has reported Prepaid Assets for 5 years, with the latest figure at $545000.0 in Q1 2026.

  • On a quarterly basis, Prepaid Assets changed N/A year-over-year to $545000.0 in Q1 2026; TTM through Mar 2026 was $545000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $535000.0, down 18.07% from the prior year.
  • Prepaid Assets was $545000.0 for Q1 2026 at Genelux, up from $535000.0 in the prior quarter.
  • The five-year high for Prepaid Assets was $1.9 million in Q3 2024, with the low at $535000.0 in Q4 2025.
  • Average Prepaid Assets over 5 years is $1.1 million, with a median of $1.2 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 45.8% in 2024, then plunged 66.65% in 2025.
  • Over 5 years, Prepaid Assets stood at $1.5 million in 2022, then plunged by 32.31% to $1.0 million in 2023, then plunged by 35.47% to $653000.0 in 2024, then retreated by 18.07% to $535000.0 in 2025, then increased by 1.87% to $545000.0 in 2026.
  • The last three Prepaid Assets figures came in at $545000.0 (Q1 2026), $535000.0 (Q4 2025), and $637000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Genelux 108.17 Mn 108.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 545,000.00
Dec 31, 2025 535,000.00
Sep 30, 2025 637,000.00
Jun 30, 2025 1.26 Mn
Dec 31, 2024 653,000.00
Sep 30, 2024 1.91 Mn
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.58 Mn
Dec 31, 2023 1.01 Mn
Sep 30, 2023 1.31 Mn
Dec 31, 2022 1.50 Mn